These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30073960)

  • 21. [Severe anaphylactic shock after the intramuscular injection of dilminal-D].
    Kropchin NM; Olesov NB; Artemenkov KG
    Vestn Khir Im I I Grek; 1979 Apr; 122(4):110. PubMed ID: 442430
    [No Abstract]   [Full Text] [Related]  

  • 22. Anaphylactic shock following povidone.
    Gonzalo Garijo MA; Durán Quintana JA; Bobadilla González P; Máiquez Asuero P
    Ann Pharmacother; 1996 Jan; 30(1):37-40. PubMed ID: 8773164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgE-Mediated Anaphylaxis Induced by Macrogol 6000.
    Caballero ML; Lluch-Bernal M; Vilà-Nadal G; Lluncor M; Quirce S
    J Investig Allergol Clin Immunol; 2016; 26(6):398-400. PubMed ID: 27996956
    [No Abstract]   [Full Text] [Related]  

  • 24. Anaphylaxis Due to the Excipient Polysorbate 80.
    Palacios Castaño MI; Venturini Díaz M; Lobera Labairu T; González Mahave I; Del Pozo Gil MD; Blasco Sarramián A
    J Investig Allergol Clin Immunol; 2016; 26(6):394-396. PubMed ID: 27996954
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anaphylaxis in cattle].
    Kamphuis A
    Tijdschr Diergeneeskd; 1996 May; 121(9):267. PubMed ID: 8693478
    [No Abstract]   [Full Text] [Related]  

  • 26. The gelatin story.
    Kelso JM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):200-2. PubMed ID: 9949308
    [No Abstract]   [Full Text] [Related]  

  • 27. Anaphylactic events observed within 4 h of ocular application of an antibiotic-containing ophthalmic preparation: 61 cats (1993-2010).
    Hume-Smith KM; Groth AD; Rishniw M; Walter-Grimm LA; Plunkett SJ; Maggs DJ
    J Feline Med Surg; 2011 Oct; 13(10):744-51. PubMed ID: 21906985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the force effect of aqueous and oily eye drops.
    Müller F; Wagner M; Neubert RH
    Pharmazie; 2005 Apr; 60(4):283-7. PubMed ID: 15881609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylaxis to macrogol 4000 after a parenteral corticoid injection.
    Dewachter P; Mouton-Faivre C
    Allergy; 2005 May; 60(5):705-6. PubMed ID: 15813822
    [No Abstract]   [Full Text] [Related]  

  • 30. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study.
    Amrane M; Creuzot-Garcher C; Robert PY; Ismail D; Garrigue JS; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 2014 Oct; 37(8):589-98. PubMed ID: 25127703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use.
    Wykoff CC; Flynn HW; Han DP
    Am J Ophthalmol; 2011 Jan; 151(1):4-6. PubMed ID: 21163372
    [No Abstract]   [Full Text] [Related]  

  • 32. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
    Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
    Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyvinylpyrrolidone deposition disease in patients with intravenous opioid use: a case series.
    Leh F; Stalund IV; Bjånes TK; Ohldieck C; Svarstad E; Leh S
    Hum Pathol; 2021 Oct; 116():102-111. PubMed ID: 34329652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylaxis Due to Poloxamer 238.
    Carbonell A; Escudero AI; Miralles JC; González A; Navarro C; Cardona P; Jimeno L; Pineda F
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):419-420. PubMed ID: 30530388
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term tolerance of preservative-free eye drops containing macrogol hydroxystearate as an excipient.
    Viaud-Quentric K; Lefranc-Jullien S; Feraille L; Elena PP
    J Fr Ophtalmol; 2016 Feb; 39(2):156-63. PubMed ID: 26832317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicated ocular bandages and corneal health: potential excipients and active pharmaceutical ingredients.
    Zidan G; Rupenthal ID; Greene C; Seyfoddin A
    Pharm Dev Technol; 2018 Mar; 23(3):255-260. PubMed ID: 28875742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis.
    Schuhman G; Vidic B
    J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Managing treatment side effects: the respective roles of the active ingredient and the preservative].
    Aptel F; Denis P; Baudouin C
    J Fr Ophtalmol; 2011 Jun; 34(6):409-12. PubMed ID: 21511364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic pharmaceutical agents: side effects encountered in a study of 15,000 applications.
    Yolton DP; Kandel JS; Yolton RL
    J Am Optom Assoc; 1980 Feb; 51(2):113-8. PubMed ID: 6768788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prednisolone eye drops. A trial of the effects of prednisolone phosphate eye drops on the intra-ocular pressure of normal volunteers.
    Ramsell TG; Trillwood W; Draper G
    Br J Ophthalmol; 1967 Jun; 51(6):398-402. PubMed ID: 5338280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.